tiprankstipranks
Trending News
More News >
Shin Nippon Biomedical Laboratories, Ltd. (JP:2395)
:2395
Japanese Market
Advertisement

Shin Nippon Biomedical Laboratories, Ltd. (2395) Income Statement

Compare
2 Followers

Shin Nippon Biomedical Laboratories, Ltd. Income Statement

Last quarter (Q3 2024), Shin Nippon Biomedical Laboratories, Ltd.'s total revenue was ¥9.73B, an increase of 59.44% from the same quarter last year. In Q3, Shin Nippon Biomedical Laboratories, Ltd.'s net income was ¥1.87B. See Shin Nippon Biomedical Laboratories, Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 32.41B¥ 26.45B¥ 25.09B¥ 17.75B¥ 15.11B
Gross Profit
¥ 16.57B¥ 14.28B¥ 13.05B¥ 9.69B¥ 7.55B
Operating Expenses
¥ 13.59B¥ 10.12B¥ 7.80B¥ 5.49B¥ 5.02B
Depreciation and Amortization
¥ 2.61B¥ 1.87B¥ 1.60B¥ 1.18B¥ 1.19B
EBITDA
¥ 8.83B¥ 8.98B¥ 9.49B¥ 9.49B¥ 5.55B
Operating Income
¥ 2.99B¥ 4.16B¥ 5.25B¥ 4.20B¥ 2.53B
Other Income/Expenses
¥ 3.03B¥ 2.81B¥ 2.51B¥ 3.99B¥ 1.65B
Pretax Income
¥ 6.01B¥ 6.97B¥ 7.76B¥ 8.18B¥ 4.18B
Net Income
¥ 4.92B¥ 5.53B¥ 6.06B¥ 7.13B¥ 3.66B
Per Share Metrics
Basic EPS
¥ 118.30¥ 132.86¥ 145.57¥ 171.21¥ 87.96
Diluted EPS
¥ 118.30¥ 132.86¥ 145.57¥ 171.21¥ 87.96
Weighted Average Shares Outstanding
41.63M 41.63M 41.63M 41.63M 41.63M
Weighted Average Shares Outstanding (Diluted)
41.63M 41.63M 41.63M 41.63M 41.63M
Currency in JPY

Shin Nippon Biomedical Laboratories, Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis